Table 2.
Additional issues for sexual violence survivors
| Sexual assault services available 24/7 | 4 |
| Record time since assault | 8 |
| Record type of assault | 8 |
| Vaginal swabs | 8 |
| Anal swabs | 6 |
| Oral swabs | 6 |
| Collect hair and fibers | 5 |
| Risk of pregnancy | 8 |
| Emergency contraception within 5 days SV | 8 |
| Levonorgestrel (1 or doses) | 6 |
| Combined estrogen/progesterone | 5 |
| Copper bearing IUD | 1 |
| Ulipristal acetate | 0 |
| Referral for abortion if legal and requested | 4 |
| Risk of STIs | 8 |
| STI testing before treatment (not recommended) | 1 |
| Chlamydia treatment | 7 |
| Gonorrhea treatment | 7 |
| Trichomonas treatment | 7 |
| Syphilis treatment | 6 |
| Hepatitis B vaccine offered (without immunoglobulin) | 5 |
| Risk of HIV | 8 |
| HIV PEP appropriateness counselling | 6 |
| Shared decision making for HIV PEP | 5 |
| Does not require HIV testing before PEP | 12 |
| Start HIV PEP within 72 h | 6 |
| HIV testing and counselling at initial consultation | 8 |
| Regular follow-ups | 5 |
| 2 drug regime for HIV PEP | 4 |
| 3 drug regime for HIV PEP | 4 |
| Prioritize drugs with fewer side effects | 1 |
| Drugs follow national guidelines | 5 |
| Adherence counselling offered | 5 |